{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:52:38Z","timestamp":1780570358854,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16017298"],"award-info":[{"award-number":["16017298"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17047023"],"award-info":[{"award-number":["17047023"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15390317"],"award-info":[{"award-number":["15390317"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.vaccine.2006.04.049","type":"journal-article","created":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T11:16:36Z","timestamp":1147432596000},"page":"5700-5707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components"],"prefix":"10.1016","volume":"24","author":[{"given":"Yoshiyuki","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Watari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hiromatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Norose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuya","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2006.04.049_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.vaccine.2006.04.049_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0966-842X(00)88986-6","article-title":"BCG vaccination against tuberculosis: past disappointments and future hopes","volume":"3","author":"Roche","year":"1995","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2006.04.049_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.iy.11.040193.001021","article-title":"Immunity to intracellular bacteria","volume":"11","author":"Kaufmann","year":"1993","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.049_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/iai.64.1.1-9.1996","article-title":"Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains","volume":"64","author":"Lagranderie","year":"1996","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2006.04.049_bib5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1084\/jem.189.12.1973","article-title":"Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis","volume":"189","author":"Behar","year":"1999","journal-title":"J Exp Med"},{"issue":"24","key":"10.1016\/j.vaccine.2006.04.049_bib6","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6507","key":"10.1016\/j.vaccine.2006.04.049_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/372691a0","article-title":"Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells","volume":"372","author":"Beckman","year":"1994","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2006.04.049_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1084\/jem.20031097","article-title":"Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis","volume":"199","author":"Gilleron","year":"2004","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2006.04.049_bib9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20041429","article-title":"Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells","volume":"200","author":"Matsunaga","year":"2004","journal-title":"J Exp Med"},{"issue":"5336","key":"10.1016\/j.vaccine.2006.04.049_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.278.5336.283","article-title":"Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells","volume":"278","author":"Moody","year":"1997","journal-title":"Science"},{"issue":"5657","key":"10.1016\/j.vaccine.2006.04.049_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.1089353","article-title":"T cell activation by lipopeptide antigens","volume":"303","author":"Moody","year":"2004","journal-title":"Science"},{"issue":"5221","key":"10.1016\/j.vaccine.2006.04.049_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.7542404","article-title":"CD1-restricted T cell recognition of microbial lipoglycan antigens","volume":"269","author":"Sieling","year":"1995","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2006.04.049_bib13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.4049\/jimmunol.168.3.1294","article-title":"Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity","volume":"168","author":"Jiao","year":"2002","journal-title":"J Immunol"},{"issue":"6780","key":"10.1016\/j.vaccine.2006.04.049_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/35009119","article-title":"CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection","volume":"404","author":"Moody","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2006.04.049_bib15","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/IAI.71.6.3076-3087.2003","article-title":"T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection","volume":"71","author":"Ulrichs","year":"2003","journal-title":"Infect Immun"},{"issue":"5386","key":"10.1016\/j.vaccine.2006.04.049_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"issue":"5319","key":"10.1016\/j.vaccine.2006.04.049_bib17","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.276.5319.1684","article-title":"Differential effects of cytolytic T cell subsets on intracellular infection","volume":"276","author":"Stenger","year":"1997","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2006.04.049_bib18","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.4049\/jimmunol.170.11.5345","article-title":"Cutting edge: Major CD8 T cell response to live bacillus Calmette-Guerin is mediated by CD1 molecules","volume":"170","author":"Kawashima","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.04.049_bib19","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.4049\/jimmunol.163.10.5478","article-title":"Conservation of a CD1 multigene family in the guinea pig","volume":"163","author":"Dascher","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.049_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4049\/jimmunol.169.1.330","article-title":"Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens","volume":"169","author":"Hiromatsu","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.049_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2567.2002.01422.x","article-title":"Characterization of guinea-pig group 1 CD1 proteins","volume":"106","author":"Hiromatsu","year":"2002","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.049_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.189.1.195","article-title":"Molecular recognition of lipid antigens by T cell receptors","volume":"189","author":"Grant","year":"1999","journal-title":"J Exp Med"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2006.04.049_bib23","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/S0264-410X(00)00429-1","article-title":"Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin","volume":"19","author":"Klunner","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2006.04.049_bib24","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.4049\/jimmunol.169.12.6951","article-title":"Conservation of CD1 intracellular trafficking patterns between mammalian species","volume":"169","author":"Dascher","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.049_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2567.2002.01422.x","article-title":"Characterization of guinea-pig group 1 CD1 proteins","volume":"106","author":"Hiromatsu","year":"2002","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2006.04.049_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1074-7613(00)80148-X","article-title":"Separate pathways for antigen presentation by CD1 molecules","volume":"11","author":"Sugita","year":"1999","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.049_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0928-8244(03)00172-X","article-title":"Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy","volume":"39","author":"Glatman-Freedman","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.04.049_bib28","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1128\/JCM.39.10.3603-3608.2001","article-title":"Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis","volume":"39","author":"Maekura","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.04.049_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.174.4.881","article-title":"Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast","volume":"174","author":"Hart","year":"1991","journal-title":"J Exp Med"},{"issue":"5147","key":"10.1016\/j.vaccine.2006.04.049_bib30","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.8303277","article-title":"Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase","volume":"263","author":"Sturgill-Koszycki","year":"1994","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2006.04.049_bib31","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.194.10.1421","article-title":"Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation","volume":"194","author":"Ramachandra","year":"2001","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2006.04.049_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1074-7613(02)00311-4","article-title":"Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells","volume":"16","author":"Sugita","year":"2002","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.vaccine.2006.04.049_bib33","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1073\/pnas.150236797","article-title":"CD1c molecules broadly survey the endocytic system","volume":"97","author":"Sugita","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2006.04.049_bib34","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.4049\/jimmunol.153.6.2568","article-title":"Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages","volume":"153","author":"Xu","year":"1994","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.04.049_bib35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/intimm\/dxg091","article-title":"Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis","volume":"15","author":"Dascher","year":"2003","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.04.049_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1074-7613(00)80539-7","article-title":"The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens","volume":"8","author":"Jackman","year":"1998","journal-title":"Immunity"},{"issue":"6404","key":"10.1016\/j.vaccine.2006.04.049_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/360593a0","article-title":"CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen","volume":"360","author":"Porcelli","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2006.04.049_bib38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm1246","article-title":"TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells","volume":"11","author":"Krutzik","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2006.04.049_bib39","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4049\/jimmunol.175.3.1758","article-title":"Mycobacterium tuberculosis Regulates CD1 Antigen Presentation Pathways through TLR-2","volume":"175","author":"Roura-Mir","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.04.049_bib40","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.164.4.2016","article-title":"Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages","volume":"164","author":"Keane","year":"2000","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.04.049_bib41","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm906","article-title":"Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis","volume":"9","author":"Schaible","year":"2003","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.vaccine.2006.04.049_bib42","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.049_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/glycob\/8.2.113","article-title":"Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects","volume":"8","author":"Chatterjee","year":"1998","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.049_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20021229","article-title":"Mycobacteria target DC-SIGN to suppress dendritic cell function","volume":"197","author":"Geijtenbeek","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2006.04.049_bib45","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1099\/00221287-139-11-2649","article-title":"Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG","volume":"139","author":"Prinzis","year":"1993","journal-title":"J Gen Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.04.049_bib46","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.4049\/jimmunol.165.9.5338","article-title":"Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c","volume":"165","author":"Sieling","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.04.049_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.trstmh.2004.08.006","article-title":"PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis","volume":"99","author":"Elias","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:14:59Z","timestamp":1759400099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06004993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":47,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0264410X06004993"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.04.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}